What Are the Therapeutic Implications of Targeting Metabolic Networks?
Targeting metabolic networks offers a promising approach to cancer therapy. Inhibitors of key metabolic enzymes, such as glutaminase inhibitors and IDH inhibitors, have shown potential in preclinical and clinical studies. Additionally, dietary interventions and metabolic modulators are being explored to selectively target cancer cell metabolism without affecting normal cells.
